| Current concepts in the diagnosis and management of cytokine release syndrome DW Lee, R Gardner, DL Porter, CU Louis, N Ahmed, M Jensen, SA Grupp, ... Blood, The Journal of the American Society of Hematology 124 (2), 188-195, 2014 | 2773 | 2014 |
| Human epidermal growth factor receptor 2 (HER2)–specific chimeric antigen receptor–modified T cells for the immunotherapy of HER2-positive sarcoma N Ahmed, VS Brawley, M Hegde, C Robertson, A Ghazi, C Gerken, E Liu, ... Journal of clinical oncology 33 (15), 1688, 2015 | 1008 | 2015 |
| Her2-specific chimeric antigen receptor–modified virus-specific t cells for progressive glioblastoma: a phase 1 dose-escalation trial N Ahmed, V Brawley, M Hegde, K Bielamowicz, M Kalra, D Landi, ... JAMA oncology 3 (8), 1094-1101, 2017 | 699 | 2017 |
| Tandem CAR T cells targeting HER2 and IL13Rα2 mitigate tumor antigen escape M Hegde, M Mukherjee, Z Grada, A Pignata, D Landi, SA Navai, ... The Journal of clinical investigation 126 (8), 3036-3052, 2016 | 631 | 2016 |
| TanCAR: a novel bispecific chimeric antigen receptor for cancer immunotherapy Z Grada, M Hegde, T Byrd, DR Shaffer, A Ghazi, VS Brawley, A Corder, ... Molecular Therapy-Nucleic Acids 2, e105, 2013 | 511 | 2013 |
| Identification of diverse astrocyte populations and their malignant analogs CCJ Lin, K Yu, A Hatcher, TW Huang, HK Lee, J Carlson, MC Weston, ... Nature neuroscience 20 (3), 396-405, 2017 | 452 | 2017 |
| HER2-specific T cells target primary glioblastoma stem cells and induce regression of autologous experimental tumors N Ahmed, VS Salsman, Y Kew, D Shaffer, S Powell, YJ Zhang, ... Clinical cancer research 16 (2), 474-485, 2010 | 402 | 2010 |
| Combinational targeting offsets antigen escape and enhances effector functions of adoptively transferred T cells in glioblastoma M Hegde, A Corder, KKH Chow, M Mukherjee, A Ashoori, Y Kew, ... Molecular Therapy 21 (11), 2087-2101, 2013 | 395 | 2013 |
| Corrigendum to “Combinational Targeting Offsets Antigen Escape and Enhances Effector Functions of Adoptively Transferred T Cells in Glioblastoma” M Hegde, A Corder, KKH Chow, M Mukherjee, A Ashoori, Y Kew, ... Molecular Therapy 21, 2087-2101, 2012 | 395* | 2012 |
| Trivalent CAR T cells overcome interpatient antigenic variability in glioblastoma K Bielamowicz, K Fousek, TT Byrd, H Samaha, M Mukherjee, N Aware, ... Neuro-oncology 20 (4), 506-518, 2018 | 373 | 2018 |
| T cells redirected to EphA2 for the immunotherapy of glioblastoma KKH Chow, S Naik, S Kakarla, VS Brawley, DR Shaffer, Z Yi, N Rainusso, ... Molecular Therapy 21 (3), 629-637, 2013 | 269 | 2013 |
| Immunotherapy for osteosarcoma: genetic modification of T cells overcomes low levels of tumor antigen expression N Ahmed, VS Salsman, E Yvon, CU Louis, L Perlaky, WS Wels, ... Molecular Therapy 17 (10), 1779-1787, 2009 | 221 | 2009 |
| Regression of experimental medulloblastoma following transfer of HER2-specific T cells N Ahmed, M Ratnayake, B Savoldo, L Perlaky, G Dotti, WS Wels, ... Cancer research 67 (12), 5957-5964, 2007 | 189 | 2007 |
| Nanoshell-mediated photothermal therapy improves survival in a murine glioma model ES Day, PA Thompson, L Zhang, NA Lewinski, N Ahmed, RA Drezek, ... Journal of neuro-oncology 104 (1), 55-63, 2011 | 175 | 2011 |
| Immunogenicity of CAR T cells in cancer therapy DL Wagner, E Fritsche, MA Pulsipher, N Ahmed, M Hamieh, M Hegde, ... Nature Reviews Clinical Oncology 18 (6), 379-393, 2021 | 163 | 2021 |
| PiggyBac-mediated cancer immunotherapy using EBV-specific cytotoxic T-cells expressing HER2-specific chimeric antigen receptor Y Nakazawa, LE Huye, VS Salsman, AM Leen, N Ahmed, L Rollins, ... Molecular Therapy 19 (12), 2133-2143, 2011 | 162 | 2011 |
| Locoregional delivery of CAR T cells to the cerebrospinal fluid for treatment of metastatic medulloblastoma and ependymoma LK Donovan, A Delaidelli, SK Joseph, K Bielamowicz, K Fousek, ... Nature medicine 26 (5), 720-731, 2020 | 161 | 2020 |
| TEM8/ANTXR1-specific CAR T cells as a targeted therapy for triple-negative breast cancer TT Byrd, K Fousek, A Pignata, C Szot, H Samaha, S Seaman, ... Cancer research 78 (2), 489-500, 2018 | 139 | 2018 |
| CAR T-cells that target acute B-lineage leukemia irrespective of CD19 expression K Fousek, J Watanabe, SK Joseph, A George, X An, TT Byrd, JS Morris, ... Leukemia 35 (1), 75-89, 2021 | 137 | 2021 |
| Tumor response and endogenous immune reactivity after administration of HER2 CAR T cells in a child with metastatic rhabdomyosarcoma M Hegde, SK Joseph, F Pashankar, C DeRenzo, K Sanber, S Navai, ... Nature communications 11 (1), 1-15, 2020 | 116 | 2020 |
